| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidoglycan muralytic activity | 4.81e-06 | 15 | 158 | 4 | GO:0061783 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | UBAP2 DSP OLFM4 NLGN1 ITGA2 ITGAE KIRREL3 FASN PTPRD PTPRF PTPRH PTPRJ NECTIN1 TNKS1BP1 PLCB3 TNR NOS3 | 5.60e-06 | 599 | 158 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 8.29e-06 | 17 | 158 | 4 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 8.29e-06 | 17 | 158 | 4 | GO:0019198 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.78e-05 | 103 | 158 | 7 | GO:0004725 | |
| GeneOntologyMolecularFunction | phosphatase activity | ACP5 PPEF1 NT5C1B PTPN7 PTPRC PTPRD PTPRF PTPRH PTPRJ PTPRS TNS1 | 1.85e-05 | 287 | 158 | 11 | GO:0016791 |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 2.01e-05 | 189 | 158 | 9 | GO:0004721 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | ACP5 PPEF1 NT5C1B PTPN7 PTPRC PTPRD PTPRF PTPRH PTPRJ PTPRS PLCB3 TNS1 | 6.00e-05 | 386 | 158 | 12 | GO:0042578 |
| GeneOntologyMolecularFunction | lysozyme activity | 7.66e-05 | 11 | 158 | 3 | GO:0003796 | |
| GeneOntologyMolecularFunction | collagen binding | 4.60e-04 | 81 | 158 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 5.02e-04 | 20 | 158 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 7.06e-04 | 51 | 158 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 8.64e-04 | 93 | 158 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | collagen receptor activity | 9.14e-04 | 6 | 158 | 2 | GO:0038064 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.01e-03 | 144 | 158 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | cullin family protein binding | 1.11e-03 | 26 | 158 | 3 | GO:0097602 | |
| GeneOntologyMolecularFunction | splicing factor binding | 1.27e-03 | 7 | 158 | 2 | GO:1990935 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.37e-03 | 103 | 158 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 1.53e-03 | 29 | 158 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.69e-03 | 8 | 158 | 2 | GO:0140945 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | ARHGAP32 HLA-A MYO5B DDR2 POU3F2 NLGN1 CSMD3 GSK3A IL1RAPL1 PTPRD PTPRF PTPRS P3H1 CSPG4 FYN TNR ARHGAP33 | 4.87e-06 | 612 | 158 | 17 | GO:0010975 |
| GeneOntologyBiologicalProcess | neuron projection development | ARHGAP32 LHX4 HLA-A MYO5B DDR2 POU3F2 NLGN1 TECTA CSMD3 GSK3A IL1RAPL1 KIRREL3 ABLIM1 GRXCR2 PTPRD PTPRF PTPRS P3H1 CSPG4 NECTIN1 ITSN2 HERC1 FYN TNR ARHGAP33 NCK2 | 5.05e-06 | 1285 | 158 | 26 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | ARHGAP32 LHX4 HLA-A MYO5B DDR2 POU3F2 NLGN1 TECTA CSMD3 GSK3A CRB1 IL1RAPL1 KIRREL3 ABLIM1 GRXCR2 PTPRD PTPRF PTPRS P3H1 CSPG4 NECTIN1 ITSN2 C3 HERC1 FYN TNR ARHGAP33 NCK2 | 5.97e-06 | 1463 | 158 | 28 | GO:0048666 |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.68e-05 | 42 | 158 | 5 | GO:0099560 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ARHGAP32 HLA-A MYO5B DDR2 POU3F2 NLGN1 ITGA2 CSMD3 GSK3A KCTD17 IL1RAPL1 PTPRD PTPRF PTPRS P3H1 CSPG4 FYN TNR ARHGAP33 | 3.50e-05 | 863 | 158 | 19 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of cell growth | ARHGAP32 FLT4 LAMTOR2 MYO5B RBM10 GSK3A KLHL22 PTPRJ PTPRS P3H1 ITSN2 CCAR2 ROS1 TNR | 4.79e-05 | 519 | 158 | 14 | GO:0001558 |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 5.09e-05 | 10 | 158 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | dendrite development | MYO5B NLGN1 CSMD3 GSK3A IL1RAPL1 PTPRD PTPRF PTPRS FYN ARHGAP33 NCK2 | 5.67e-05 | 335 | 158 | 11 | GO:0016358 |
| GeneOntologyBiologicalProcess | cell junction organization | LAMTOR2 MYO5B DSP NLGN1 ITGA2 IL1RAPL1 KIRREL3 LSR PTPRD PTPRF PTPRJ PTPRS NECTIN1 CNTNAP4 C3 BSN FYN TNR TNS1 ARHGAP33 | 5.71e-05 | 974 | 158 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | TCF4 FLT4 PDK4 DDR2 GSK3A HHIP ADIPOQ PTPRF PTPRJ DOK4 CSPG4 ROS1 FYN SLC30A10 FOXC1 NCK2 KLB | 6.19e-05 | 747 | 158 | 17 | GO:0007169 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by trans-synaptic complex | 6.96e-05 | 11 | 158 | 3 | GO:0099545 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ARHGAP32 HLA-A MYO5B DDR2 POU3F2 NLGN1 CSMD3 GSK3A KCTD17 IL1RAPL1 PTPRD PTPRF PTPRS P3H1 CSPG4 FYN TNR ARHGAP33 | 8.81e-05 | 846 | 158 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | cell growth | ARHGAP32 FLT4 LAMTOR2 MYO5B RBM10 GSK3A KLHL22 PTPRJ PTPRS P3H1 FUBP1 ITSN2 CCAR2 ROS1 TNR | 9.54e-05 | 625 | 158 | 15 | GO:0016049 |
| GeneOntologyBiologicalProcess | presynapse assembly | 9.62e-05 | 60 | 158 | 5 | GO:0099054 | |
| GeneOntologyBiologicalProcess | regulation of growth | ARHGAP32 FLT4 LAMTOR2 MYO5B RBM10 POU3F2 GSK3A KLHL22 PTPRJ PTPRS P3H1 ITSN2 CCAR2 C3 ROS1 TNR FOXC1 | 1.00e-04 | 777 | 158 | 17 | GO:0040008 |
| GeneOntologyBiologicalProcess | dendritic spine development | 1.09e-04 | 141 | 158 | 7 | GO:0060996 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.19e-04 | 13 | 158 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.22e-04 | 63 | 158 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation | 1.29e-04 | 34 | 158 | 4 | GO:0035335 | |
| GeneOntologyBiologicalProcess | RNA splicing | RBMXL3 RBM3 RBM10 NUP98 SLU7 WTAP NCBP2 SF3B1 ZRANB2 RBM14 CCAR2 TAF15 TGS1 | 1.35e-04 | 502 | 158 | 13 | GO:0008380 |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 1.59e-04 | 150 | 158 | 7 | GO:0050830 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 1.63e-04 | 256 | 158 | 9 | GO:0006470 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ARHGAP32 LHX4 MYO5B POU3F2 NLGN1 TECTA IL1RAPL1 ABLIM1 GRXCR2 PTPRD PTPRF PTPRS NECTIN1 FYN TNR ARHGAP33 | 2.08e-04 | 748 | 158 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | presynapse organization | 2.44e-04 | 73 | 158 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | TCF4 ARHGAP32 FLT4 MYO5B POU3F2 NLGN1 IL1RAPL1 FAM171A1 HHIP PTPRD PTPRF PTPRS ITSN2 C3 C5 FYN TNR NOS3 ARHGAP33 FOXC1 | 2.58e-04 | 1090 | 158 | 20 | GO:0022603 |
| GeneOntologyBiologicalProcess | dendritic spine organization | 2.60e-04 | 115 | 158 | 6 | GO:0097061 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | ARHGAP32 LHX4 MYO5B POU3F2 NLGN1 TECTA CRB1 IL1RAPL1 FAM171A1 KIRREL3 ABLIM1 GRXCR2 PTPRD PTPRF PTPRJ PTPRS NECTIN1 ITSN2 FYN TNR ARHGAP33 | 3.17e-04 | 1194 | 158 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of glycogen (starch) synthase activity | 3.46e-04 | 4 | 158 | 2 | GO:2000467 | |
| GeneOntologyBiologicalProcess | dephosphorylation | 3.53e-04 | 347 | 158 | 10 | GO:0016311 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 3.83e-04 | 228 | 158 | 8 | GO:0046777 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 3.97e-04 | 81 | 158 | 5 | GO:0060997 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 4.43e-04 | 233 | 158 | 8 | GO:0031345 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 4.43e-04 | 127 | 158 | 6 | GO:0106027 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ARHGAP32 LHX4 MYO5B POU3F2 NLGN1 IL1RAPL1 KIRREL3 ABLIM1 PTPRD PTPRF PTPRS NECTIN1 ITSN2 FYN TNR ARHGAP33 | 4.51e-04 | 802 | 158 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 4.51e-04 | 358 | 158 | 10 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 4.51e-04 | 358 | 158 | 10 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 4.92e-04 | 362 | 158 | 10 | GO:0000375 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 5.30e-04 | 21 | 158 | 3 | GO:0099151 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 5.37e-04 | 49 | 158 | 4 | GO:0050685 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ARHGAP32 LHX4 MYO5B POU3F2 NLGN1 IL1RAPL1 KIRREL3 ABLIM1 PTPRD PTPRF PTPRS NECTIN1 ITSN2 FYN TNR ARHGAP33 | 5.65e-04 | 819 | 158 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 5.70e-04 | 185 | 158 | 7 | GO:0099175 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 5.74e-04 | 5 | 158 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | negative regulation of CREB transcription factor activity | 5.74e-04 | 5 | 158 | 2 | GO:0032792 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 5.89e-04 | 134 | 158 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ARHGAP32 LHX4 MYO5B POU3F2 NLGN1 IL1RAPL1 KIRREL3 ABLIM1 PTPRD PTPRF PTPRS NECTIN1 ITSN2 FYN TNR ARHGAP33 | 6.20e-04 | 826 | 158 | 16 | GO:0048858 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ARHGAP32 NLGN1 IL1RAPL1 ABLIM1 PTPRD PTPRF PTPRS NECTIN1 ARFGAP1 BSN FYN TNR NCK2 KLHL17 | 3.91e-05 | 523 | 156 | 14 | GO:0098984 |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 4.71e-05 | 10 | 156 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | secretory vesicle | A1BG NAPSA ADGRG3 LAMTOR2 DSP LYZL4 ACLY UBR4 SRI OLFM4 FNDC3A F8 KIRREL3 PTPRC PTPRJ PTPRS NXF2 C3 BSN BACE2 LYZ SLC30A10 ZG16 | 5.24e-05 | 1246 | 156 | 23 | GO:0099503 |
| GeneOntologyCellularComponent | mucus layer | 1.65e-04 | 3 | 156 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 2.00e-04 | 39 | 156 | 4 | GO:0031463 | |
| GeneOntologyCellularComponent | secretory granule | A1BG NAPSA ADGRG3 LAMTOR2 DSP LYZL4 ACLY UBR4 SRI OLFM4 FNDC3A F8 PTPRC PTPRJ NXF2 C3 BACE2 LYZ ZG16 | 2.05e-04 | 1014 | 156 | 19 | GO:0030141 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.06e-04 | 18 | 156 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | vesicle membrane | ARHGAP32 ADGRG3 LZTR1 LAMTOR2 HLA-A MYO5B DSP SNX17 UBR4 SRI MR1 FNDC3A PTPRC PTPRJ SLC15A2 PTPRS BSN BACE2 SLC30A10 NOS3 NCK2 ZG16 | 3.47e-04 | 1325 | 156 | 22 | GO:0012506 |
| GeneOntologyCellularComponent | postsynaptic specialization | ARHGAP32 NLGN1 CHRNE IL1RAPL1 ABLIM1 PTPRF PTPRS ARFGAP1 BSN FYN NCK2 KLHL17 | 4.05e-04 | 503 | 156 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.23e-04 | 20 | 156 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.91e-04 | 21 | 156 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | postsynaptic density | ARHGAP32 NLGN1 IL1RAPL1 ABLIM1 PTPRF PTPRS ARFGAP1 BSN FYN NCK2 KLHL17 | 5.89e-04 | 451 | 156 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A1BG NID2 HTRA1 FBLN2 ADIPOQ P3H1 CSPG4 PZP MUC2 TNR ANGPTL7 ZG16 | 6.44e-04 | 530 | 156 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | asymmetric synapse | ARHGAP32 NLGN1 IL1RAPL1 ABLIM1 PTPRF PTPRS ARFGAP1 BSN FYN NCK2 KLHL17 | 9.32e-04 | 477 | 156 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 9.87e-04 | 59 | 156 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 1.10e-03 | 155 | 156 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | specific granule | 1.29e-03 | 160 | 156 | 6 | GO:0042581 | |
| GeneOntologyCellularComponent | extracellular matrix | A1BG NID2 HTRA1 TECTA FBLN2 ADIPOQ P3H1 CSPG4 PZP MUC2 TNR ANGPTL7 ZG16 | 1.31e-03 | 656 | 156 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A1BG NID2 HTRA1 TECTA FBLN2 ADIPOQ P3H1 CSPG4 PZP MUC2 TNR ANGPTL7 ZG16 | 1.34e-03 | 658 | 156 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.50e-03 | 8 | 156 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear speck | 1.52e-03 | 431 | 156 | 10 | GO:0016607 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 1.59e-03 | 67 | 156 | 4 | GO:0098686 | |
| GeneOntologyCellularComponent | postsynapse | ARHGAP32 MYO5B SRI NLGN1 GSK3A CHRNE IL1RAPL1 ABLIM1 PTPRF PTPRS ARFGAP1 PLCB3 BSN FYN ARHGAP33 NCK2 KLHL17 | 1.60e-03 | 1018 | 156 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | cell surface | NID2 HLA-A FOLH1 MR1 NLGN1 ITGA2 ITGAE IL1RAPL1 HHIP ADIPOQ PTPRC PTPRJ CSPG4 C3 ROS1 BSN TNR TNS1 | 1.63e-03 | 1111 | 156 | 18 | GO:0009986 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ARHGAP32 ADGRG3 LZTR1 LAMTOR2 HLA-A MYO5B DSP SNX17 UBR4 SRI MR1 PTPRC PTPRJ SLC15A2 PTPRS BSN BACE2 SLC30A10 NOS3 ZG16 | 1.77e-03 | 1307 | 156 | 20 | GO:0030659 |
| GeneOntologyCellularComponent | junctional membrane complex | 1.92e-03 | 9 | 156 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 2.39e-03 | 10 | 156 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 2.39e-03 | 10 | 156 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | nuclear pore outer ring | 2.39e-03 | 10 | 156 | 2 | GO:0031080 | |
| GeneOntologyCellularComponent | secretory granule membrane | 3.35e-03 | 329 | 156 | 8 | GO:0030667 | |
| Domain | PTPc | 1.76e-08 | 36 | 157 | 7 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.18e-08 | 39 | 157 | 7 | PS50055 | |
| Domain | PTPase_domain | 4.59e-08 | 41 | 157 | 7 | IPR000242 | |
| Domain | Y_phosphatase | 4.59e-08 | 41 | 157 | 7 | PF00102 | |
| Domain | PTPc_motif | 6.13e-07 | 59 | 157 | 7 | SM00404 | |
| Domain | Tyr_Pase_cat | 6.13e-07 | 59 | 157 | 7 | IPR003595 | |
| Domain | fn3 | 1.14e-06 | 162 | 157 | 10 | PF00041 | |
| Domain | Tyr_Pase_AS | 2.65e-06 | 73 | 157 | 7 | IPR016130 | |
| Domain | FN3 | 3.79e-06 | 185 | 157 | 10 | SM00060 | |
| Domain | FN3 | 7.24e-06 | 199 | 157 | 10 | PS50853 | |
| Domain | TYR_PHOSPHATASE_1 | 7.99e-06 | 86 | 157 | 7 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 8.63e-06 | 87 | 157 | 7 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 8.63e-06 | 87 | 157 | 7 | PS50056 | |
| Domain | Kelch | 9.05e-06 | 58 | 157 | 6 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 1.00e-05 | 59 | 157 | 6 | IPR011043 | |
| Domain | FN3_dom | 1.11e-05 | 209 | 157 | 10 | IPR003961 | |
| Domain | - | 1.25e-05 | 92 | 157 | 7 | 3.90.190.10 | |
| Domain | ANATO | 1.99e-05 | 7 | 157 | 3 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 1.99e-05 | 7 | 157 | 3 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.99e-05 | 7 | 157 | 3 | PS01177 | |
| Domain | ANATO | 1.99e-05 | 7 | 157 | 3 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.99e-05 | 7 | 157 | 3 | IPR000020 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.02e-05 | 99 | 157 | 7 | IPR029021 | |
| Domain | Kelch_1 | 2.70e-05 | 70 | 157 | 6 | PF01344 | |
| Domain | Kelch_1 | 2.70e-05 | 70 | 157 | 6 | IPR006652 | |
| Domain | Ig-like_fold | A1BG FLT4 HLA-A TSPOAP1 MR1 FNDC3A IL1RAPL1 KIRREL3 LSR PTPRC PTPRD PTPRF PTPRH PTPRJ PTPRS NECTIN1 ROS1 TNR | 2.80e-05 | 706 | 157 | 18 | IPR013783 |
| Domain | BTB-kelch_protein | 2.93e-05 | 43 | 157 | 5 | IPR017096 | |
| Domain | zf-RanBP | 3.12e-05 | 22 | 157 | 4 | PF00641 | |
| Domain | ZnF_RBZ | 3.76e-05 | 23 | 157 | 4 | SM00547 | |
| Domain | ZF_RANBP2_2 | 3.76e-05 | 23 | 157 | 4 | PS50199 | |
| Domain | - | A1BG FLT4 HLA-A TSPOAP1 MR1 FNDC3A IL1RAPL1 KIRREL3 LSR PTPRC PTPRD PTPRF PTPRJ PTPRS NECTIN1 ROS1 TNR | 4.42e-05 | 663 | 157 | 17 | 2.60.40.10 |
| Domain | ZF_RANBP2_1 | 4.48e-05 | 24 | 157 | 4 | PS01358 | |
| Domain | Znf_RanBP2 | 5.30e-05 | 25 | 157 | 4 | IPR001876 | |
| Domain | Aspartic_peptidase_A1 | 6.70e-05 | 10 | 157 | 3 | IPR001461 | |
| Domain | - | 6.70e-05 | 10 | 157 | 3 | 4.10.1060.10 | |
| Domain | A2M | 6.70e-05 | 10 | 157 | 3 | PF00207 | |
| Domain | A2M_N_2 | 6.70e-05 | 10 | 157 | 3 | IPR011625 | |
| Domain | A2M_comp | 6.70e-05 | 10 | 157 | 3 | IPR011626 | |
| Domain | A2M_recep | 6.70e-05 | 10 | 157 | 3 | PF07677 | |
| Domain | A2M_comp | 6.70e-05 | 10 | 157 | 3 | PF07678 | |
| Domain | A2M_N | 6.70e-05 | 10 | 157 | 3 | PF01835 | |
| Domain | Lysozyme-like_dom | 6.70e-05 | 10 | 157 | 3 | IPR023346 | |
| Domain | A2M_N | 6.70e-05 | 10 | 157 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 6.70e-05 | 10 | 157 | 3 | IPR009048 | |
| Domain | PEPTIDASE_A1 | 6.70e-05 | 10 | 157 | 3 | IPR033121 | |
| Domain | ALPHA_2_MACROGLOBULIN | 6.70e-05 | 10 | 157 | 3 | PS00477 | |
| Domain | A2M_N_2 | 6.70e-05 | 10 | 157 | 3 | PF07703 | |
| Domain | Asp | 6.70e-05 | 10 | 157 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 6.70e-05 | 10 | 157 | 3 | PS51767 | |
| Domain | Macroglobln_a2 | 6.70e-05 | 10 | 157 | 3 | IPR001599 | |
| Domain | - | 7.25e-05 | 27 | 157 | 4 | 2.130.10.80 | |
| Domain | - | 1.21e-04 | 12 | 157 | 3 | 2.40.70.10 | |
| Domain | Quinoprot_gluc/sorb_DH | 1.21e-04 | 12 | 157 | 3 | IPR011041 | |
| Domain | ASP_PROTEASE | 1.21e-04 | 12 | 157 | 3 | PS00141 | |
| Domain | RRM_dom | 1.32e-04 | 227 | 157 | 9 | IPR000504 | |
| Domain | RRM | 1.45e-04 | 230 | 157 | 9 | PS50102 | |
| Domain | BACK | 1.48e-04 | 60 | 157 | 5 | SM00875 | |
| Domain | Aspartic_peptidase_AS | 1.57e-04 | 13 | 157 | 3 | IPR001969 | |
| Domain | BACK | 1.60e-04 | 61 | 157 | 5 | IPR011705 | |
| Domain | BACK | 1.60e-04 | 61 | 157 | 5 | PF07707 | |
| Domain | Gal_Oxidase_b-propeller | 1.83e-04 | 34 | 157 | 4 | IPR015916 | |
| Domain | MORN | 2.46e-04 | 15 | 157 | 3 | IPR003409 | |
| Domain | MORN | 2.46e-04 | 15 | 157 | 3 | PF02493 | |
| Domain | Nucleotide-bd_a/b_plait | 3.41e-04 | 258 | 157 | 9 | IPR012677 | |
| Domain | Peptidase_aspartic_dom | 3.63e-04 | 17 | 157 | 3 | IPR021109 | |
| Domain | RRM_1 | 3.83e-04 | 208 | 157 | 8 | PF00076 | |
| Domain | BTB | 4.13e-04 | 160 | 157 | 7 | PS50097 | |
| Domain | Junctophilin | 4.17e-04 | 4 | 157 | 2 | IPR017191 | |
| Domain | - | 4.17e-04 | 4 | 157 | 2 | 1.20.91.20 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.33e-04 | 18 | 157 | 3 | IPR008930 | |
| Domain | TPR_REGION | 4.97e-04 | 165 | 157 | 7 | PS50293 | |
| Domain | TPR | 4.97e-04 | 165 | 157 | 7 | PS50005 | |
| Domain | SH3_9 | 5.07e-04 | 78 | 157 | 5 | PF14604 | |
| Domain | RRM | 5.07e-04 | 217 | 157 | 8 | SM00360 | |
| Domain | NIDO_dom | 6.91e-04 | 5 | 157 | 2 | IPR003886 | |
| Domain | NIDO | 6.91e-04 | 5 | 157 | 2 | SM00539 | |
| Domain | NIDO | 6.91e-04 | 5 | 157 | 2 | PF06119 | |
| Domain | Anaphylatoxin_comp_syst | 6.91e-04 | 5 | 157 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 6.91e-04 | 5 | 157 | 2 | IPR001840 | |
| Domain | NIDO | 6.91e-04 | 5 | 157 | 2 | PS51220 | |
| Domain | FA58C | 6.93e-04 | 21 | 157 | 3 | SM00231 | |
| Domain | FA58C_3 | 6.93e-04 | 21 | 157 | 3 | PS50022 | |
| Domain | FA58C_1 | 6.93e-04 | 21 | 157 | 3 | PS01285 | |
| Domain | FA58C_2 | 6.93e-04 | 21 | 157 | 3 | PS01286 | |
| Domain | BTB | 8.32e-04 | 180 | 157 | 7 | SM00225 | |
| Domain | BTB | 8.45e-04 | 131 | 157 | 6 | PF00651 | |
| Domain | IGc2 | 8.54e-04 | 235 | 157 | 8 | SM00408 | |
| Domain | Ig_sub2 | 8.54e-04 | 235 | 157 | 8 | IPR003598 | |
| Domain | BTB/POZ_dom | 9.77e-04 | 185 | 157 | 7 | IPR000210 | |
| Domain | F5_F8_type_C | 1.04e-03 | 24 | 157 | 3 | PF00754 | |
| Domain | FA58C | 1.04e-03 | 24 | 157 | 3 | IPR000421 | |
| Domain | - | 1.09e-03 | 244 | 157 | 8 | 3.30.70.330 | |
| Domain | SKP1/BTB/POZ | 1.11e-03 | 189 | 157 | 7 | IPR011333 | |
| Domain | Glyco_hydro_22_lys | 1.43e-03 | 7 | 157 | 2 | IPR000974 | |
| Domain | Glyco_hydro_22_CS | 1.43e-03 | 7 | 157 | 2 | IPR019799 | |
| Domain | TPR-contain_dom | 1.70e-03 | 150 | 157 | 6 | IPR013026 | |
| Domain | FBG | 1.81e-03 | 29 | 157 | 3 | SM00186 | |
| Domain | Glyco_hydro_22 | 1.90e-03 | 8 | 157 | 2 | IPR001916 | |
| Domain | LACTALBUMIN_LYSOZYME_2 | 1.90e-03 | 8 | 157 | 2 | PS51348 | |
| Domain | Lys | 1.90e-03 | 8 | 157 | 2 | PF00062 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 2.98e-05 | 20 | 130 | 4 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 2.98e-05 | 20 | 130 | 4 | MM14991 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.49e-05 | 43 | 130 | 5 | MM14609 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 6.18e-05 | 9 | 130 | 3 | MM14966 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 9.38e-05 | 50 | 130 | 5 | MM14610 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.24e-04 | 84 | 130 | 6 | M725 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.36e-04 | 54 | 130 | 5 | M29594 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.41e-04 | 86 | 130 | 6 | MM15413 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.91e-04 | 58 | 130 | 5 | MM14736 | |
| Pubmed | ARHGAP32 RANBP2 LZTR1 HLA-A MYO5B DSP SNX17 NUP98 PPEF1 GSK3A FAM171A1 PTPN7 PTPRC PTPRD PTPRF PTPRH PTPRJ PTPRS P3H1 CCAR2 SETD7 HERC1 TNS1 FOXC1 NCK2 | 1.49e-11 | 1049 | 159 | 25 | 27880917 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RANBP2 LZTR1 PITRM1 DNAJC16 ACLY IFT172 UBR4 PSMB5 NUP98 PPEF1 STT3A LSR PTPN7 FASN PTPRD PTPRF PTPRH PTPRS ZRANB2 TOMM34 CCAR2 C3 | 7.59e-10 | 974 | 159 | 22 | 28675297 |
| Pubmed | 2.10e-09 | 5 | 159 | 4 | 22357843 | ||
| Pubmed | 2.80e-09 | 257 | 159 | 12 | 16335952 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANBP2 DSP ACLY RBM10 NUP98 GSK3A WTAP ABLIM1 FASN SF3B1 PTPRC FUBP1 ARFGAP1 ZRANB2 RBM14 CCAR2 TNKS1BP1 PLCB3 ANAPC5 | 3.14e-09 | 774 | 159 | 19 | 15302935 |
| Pubmed | 1.46e-08 | 7 | 159 | 4 | 12376545 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 2.77e-08 | 197 | 159 | 10 | 29872149 | |
| Pubmed | 2.90e-08 | 8 | 159 | 4 | 28637841 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ARHGAP32 LZTR1 HLA-A DNAJC16 C1orf43 SNX17 JPH2 ITGA2 JPH1 LSR PTPRF PTPRJ CSPG4 NECTIN1 PLCB3 | 6.27e-08 | 569 | 159 | 15 | 30639242 |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 9.38e-08 | 3 | 159 | 3 | 33656439 | |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 9784606 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 9.38e-08 | 3 | 159 | 3 | 31985401 | |
| Pubmed | 1.57e-07 | 87 | 159 | 7 | 37495603 | ||
| Pubmed | SETD1A RANBP2 UBAP2 HLA-A DSP UBR4 NUP98 STT3A FASN SF3B1 ARFGAP1 RBM14 TOMM34 C3 TAF15 TNS1 | 1.92e-07 | 711 | 159 | 16 | 33022573 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 2.02e-07 | 12 | 159 | 4 | 9624153 | |
| Pubmed | 2.49e-07 | 57 | 159 | 6 | 34878901 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 HLA-A MYO5B DSP ACLY RBM10 NUP98 AGPS LSR ABLIM1 FASN SF3B1 PTPRF FUBP1 RBM14 CCAR2 TAF15 FYN FOXC1 | 2.56e-07 | 1024 | 159 | 19 | 24711643 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | RANBP2 UBAP2 DSP ACLY RBM10 NUP98 FASN SF3B1 ARFGAP1 TNKS1BP1 | 3.20e-07 | 256 | 159 | 10 | 33397691 |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 8524829 | ||
| Pubmed | RBMXL3 RBM3 RBM10 ASCC1 NUP98 MSI2 SF3B1 FUBP1 RBM14 TAF15 TGS1 | 6.47e-07 | 347 | 159 | 11 | 16033648 | |
| Pubmed | LZTR1 HLA-A PITRM1 DNAJC16 RBM10 C1orf43 SNX17 NUP98 JPH1 LSR ABLIM1 P3H1 ARFGAP1 ITSN2 RBM14 PRKAR2A CCAR2 NCK2 | 9.23e-07 | 1007 | 159 | 18 | 34597346 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 10777529 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 21940441 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 28223279 | ||
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 9.56e-07 | 17 | 159 | 4 | 19727691 | |
| Pubmed | ARHGAP32 RANBP2 HLA-A TTC28 DSP ACLY FNDC3A STT3A JPH1 FAM171A1 ABLIM1 FASN ARFGAP1 TNKS1BP1 NCK2 | 1.00e-06 | 708 | 159 | 15 | 39231216 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | A1BG NAPSA MYO5B DSP ACLY PSMB5 SRI OLFM4 TECTA FASN EML5 PTPRJ SLC15A2 P3H1 ITSN2 PRKAR2A C5 LYZ | 1.05e-06 | 1016 | 159 | 18 | 19056867 |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 1.08e-06 | 226 | 159 | 9 | 37839992 | |
| Pubmed | 1.23e-06 | 41 | 159 | 5 | 23676014 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | RANBP2 HLA-A DNAJC16 ACLY C1orf43 UBR4 NUP98 FNDC3A GSK3A STT3A JPH1 LSR FASN PTPRF P3H1 PRKAR2A ANAPC5 | 1.66e-06 | 942 | 159 | 17 | 31073040 |
| Pubmed | ARHGAP32 UBAP2 DSP ACLY RBM10 UBR4 FASN SF3B1 FUBP1 RBM14 CCAR2 TAF15 PRPH | 1.69e-06 | 551 | 159 | 13 | 34728620 | |
| Pubmed | TDRD15 RGPD2 RANBP2 RBMXL3 DSP RBM3 UBR4 PSMB5 AGPS FASN SF3B1 FUBP1 RBM14 TNKS1BP1 TAF15 LYZ | 1.82e-06 | 844 | 159 | 16 | 25963833 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD2 RANBP2 DSP ACLY UBR4 PSMB5 ITGA2 KLHL22 NCBP2 FASN CCAR2 C3 TNKS1BP1 PZP | 1.83e-06 | 647 | 159 | 14 | 26618866 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.84e-06 | 179 | 159 | 8 | 36261009 | |
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 19273906 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | A1BG NAPSA NID2 FOLH1 ACLY SRI OLFM4 FASN PTPRD PTPRJ PTPRS CSPG4 PRKAR2A C3 C5 PZP LYZ PRPH | 2.17e-06 | 1070 | 159 | 18 | 23533145 |
| Pubmed | 2.21e-06 | 46 | 159 | 5 | 37207277 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.41e-06 | 130 | 159 | 7 | 35545047 | |
| Pubmed | UBAP2 RBM3 RBM10 SRI SF3B1 FUBP1 PRKAR2A CCAR2 TNKS1BP1 TAF15 SETD7 | 2.50e-06 | 399 | 159 | 11 | 35987950 | |
| Pubmed | RANBP2 HLA-A DSP ACLY UBR4 PSMB5 ABLIM1 FASN PRKAR2A CCAR2 TNKS1BP1 | 2.50e-06 | 399 | 159 | 11 | 37536630 | |
| Pubmed | ARHGAP32 HTRA1 MYO5B DSP ACLY ITGA2 ABLIM1 FASN SF3B1 PTPRS ITSN2 RBM14 PRKAR2A TNKS1BP1 TAF15 BSN LYZ TNR DNAH6 TNS1 NCK2 | 2.54e-06 | 1431 | 159 | 21 | 37142655 | |
| Pubmed | 2.81e-06 | 133 | 159 | 7 | 15144186 | ||
| Pubmed | TTC28 TSPOAP1 DNAJC16 IFT172 RBM10 NLGN1 CSMD3 KIRREL3 ABLIM1 ITSN2 CCAR2 | 3.03e-06 | 407 | 159 | 11 | 12693553 | |
| Pubmed | TDRD15 TTC28 DNAJC16 SMC6 NUP98 AGPS CRB1 LSR SF3B1 ARFGAP1 ZRANB2 RBM14 TOMM34 CCAR2 TAF15 | 3.13e-06 | 777 | 159 | 15 | 35844135 | |
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 29073098 | ||
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 1454056 | ||
| Pubmed | 3.48e-06 | 23 | 159 | 4 | 33130828 | ||
| Pubmed | TTC28 IFT172 RBM10 DDR2 NUP98 TECTA CSMD3 JPH1 SF3B1 CCAR2 KLHL18 TUBAL3 | 4.69e-06 | 513 | 159 | 12 | 25798074 | |
| Pubmed | 4.91e-06 | 272 | 159 | 9 | 31010829 | ||
| Pubmed | Usp22 deficiency impairs intestinal epithelial lineage specification in vivo. | 5.16e-06 | 8 | 159 | 3 | 26431380 | |
| Pubmed | 5.16e-06 | 8 | 159 | 3 | 37591863 | ||
| Pubmed | 5.16e-06 | 8 | 159 | 3 | 18506375 | ||
| Pubmed | RBMXL3 DSP RBM3 ACLY PSMB5 EFHB MSI2 NCBP2 FASN SF3B1 ZRANB2 RBM14 CCAR2 TAF15 FYN TUBAL3 TGS1 PRPH | 6.08e-06 | 1153 | 159 | 18 | 29845934 | |
| Pubmed | RANBP2 UBR4 PSMB5 NUP98 AGPS WTAP FASN SF3B1 NUP37 RBM14 PRKAR2A TOMM34 | 7.02e-06 | 534 | 159 | 12 | 35032548 | |
| Pubmed | UBAP2 HLA-A TTC28 DNAJC16 FNDC3A RNF40 STT3A JPH1 ABLIM1 KLHL9 TOMM34 CCAR2 NCK2 TGS1 | 7.62e-06 | 733 | 159 | 14 | 34672954 | |
| Pubmed | LAMTOR2 HLA-A DSP ACLY UBR4 SRI AGPS GSK3A STT3A FASN SF3B1 P3H1 FUBP1 ARFGAP1 PRKAR2A CCAR2 C3 TNKS1BP1 FYN | 8.15e-06 | 1297 | 159 | 19 | 33545068 | |
| Pubmed | RANBP2 DSP ACLY RBM10 NUP98 STT3A NCBP2 FASN SF3B1 ZRANB2 RBM14 TAF15 LYZ | 8.67e-06 | 641 | 159 | 13 | 36057605 | |
| Pubmed | RGPD2 ARHGAP32 RANBP2 UBAP2 UBR4 FAM171A1 ABLIM1 SF3B1 PTPRD PTPRS PRKAR2A CCAR2 TAF15 BSN TNR TNS1 | 9.61e-06 | 963 | 159 | 16 | 28671696 | |
| Pubmed | 1.03e-05 | 162 | 159 | 7 | 25826454 | ||
| Pubmed | SOX11 DSP RBM3 RBM10 SMC6 PSMB5 FNDC3A RNF40 STT3A FASN SF3B1 PTPRF FUBP1 ROS1 | 1.05e-05 | 754 | 159 | 14 | 35906200 | |
| Pubmed | FLT4 UBAP2 RBM3 RBM10 PSMB5 ASCC1 WTAP STT3A KCTD17 MSI2 NCBP2 FASN SF3B1 ZRANB2 RBM14 ANAPC5 | 1.06e-05 | 971 | 159 | 16 | 33306668 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RANBP2 UBAP2 HLA-A DSP C1orf43 DDR2 SMC6 FNDC3A ITGA2 AGPS STT3A LSR ABLIM1 FASN SF3B1 PTPRF CSPG4 LYZ | 1.08e-05 | 1203 | 159 | 18 | 29180619 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | NID2 UBAP2 HLA-A PITRM1 DSP DNAJC16 ACLY DDR2 RNF40 AGPS STT3A FASN FBLN2 ADIPOQ PTPRC P3H1 CSPG4 GFPT2 LYZ DNAH6 | 1.13e-05 | 1451 | 159 | 20 | 30550785 |
| Pubmed | Maternal synchronization of gestational length and lung maturation. | 1.20e-05 | 31 | 159 | 4 | 22096492 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.20e-05 | 231 | 159 | 8 | 16452087 | |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | RANBP2 LAMTOR2 HLA-A DNAJC16 ACLY STT3A ABLIM1 PTPRC BACE2 FYN | 1.42e-05 | 392 | 159 | 10 | 33144569 |
| Pubmed | 1.51e-05 | 11 | 159 | 3 | 25624497 | ||
| Pubmed | Paneth Cell Multipotency Induced by Notch Activation following Injury. | 1.51e-05 | 11 | 159 | 3 | 29887318 | |
| Pubmed | 1.51e-05 | 11 | 159 | 3 | 23206327 | ||
| Pubmed | 1.51e-05 | 11 | 159 | 3 | 7832766 | ||
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 1.73e-05 | 243 | 159 | 8 | 36964488 | |
| Pubmed | SETD1A UBAP2 DSP ACLY PSMB5 KLHL22 FASN SF3B1 RBM14 CCAR2 TAF15 | 1.86e-05 | 494 | 159 | 11 | 26831064 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | ACLY RBM10 PSMB5 NT5C1B KCTD17 KLHL22 FASN KLHL9 ZRANB2 KLHL18 TUBAL3 | 1.90e-05 | 495 | 159 | 11 | 28581483 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD2 RANBP2 HLA-A DSP ACLY UBR4 PSMB5 RNF40 WTAP STT3A FASN KLHL9 SF3B1 NUP37 RBM14 PRKAR2A CCAR2 TAF15 | 1.94e-05 | 1257 | 159 | 18 | 37317656 |
| Pubmed | C1q is elevated during chronic Staphylococcus epidermidis central nervous system catheter infection. | 2.08e-05 | 2 | 159 | 2 | 38881889 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24667943 | ||
| Pubmed | Complement decay-accelerating factor inhibits inflammation-induced myopia development. | 2.08e-05 | 2 | 159 | 2 | 38795684 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 21518849 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 36154586 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 23580664 | ||
| Pubmed | Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1. | 2.08e-05 | 2 | 159 | 2 | 11535622 | |
| Pubmed | Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. | 2.08e-05 | 2 | 159 | 2 | 20479009 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 25197626 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 20431061 | ||
| Pubmed | The Alzheimer's disease-linked protease BACE2 cleaves VEGFR3 and modulates its signaling. | 2.08e-05 | 2 | 159 | 2 | 38888964 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 25450682 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 25573852 | ||
| Pubmed | Alterations in plasma complement levels after human ischemic stroke. | 2.08e-05 | 2 | 159 | 2 | 16823297 | |
| Pubmed | Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice. | 2.08e-05 | 2 | 159 | 2 | 30714990 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 35114566 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 1695146 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 18990685 | ||
| Pubmed | Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity. | 2.08e-05 | 2 | 159 | 2 | 28278205 | |
| Pubmed | HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. | 2.08e-05 | 2 | 159 | 2 | 21423673 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 27859601 | ||
| Pubmed | Robust RBM3 and β-klotho expression in developing neurons in the human brain. | 2.08e-05 | 2 | 159 | 2 | 31566073 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 37547981 | ||
| Pubmed | The role of the complement anaphylatoxins in the recruitment of eosinophils. | 2.08e-05 | 2 | 159 | 2 | 18039528 | |
| Pubmed | Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment. | 2.08e-05 | 2 | 159 | 2 | 29155219 | |
| Interaction | UGT1A7 interactions | 5.71e-06 | 57 | 159 | 6 | int:UGT1A7 | |
| Interaction | OPTC interactions | 6.31e-06 | 16 | 159 | 4 | int:OPTC | |
| Interaction | FGFR4 interactions | HLA-A UBR4 TTYH2 KLHL22 JPH1 FAM171A1 LSR ABLIM1 ARFGAP1 ITSN2 ROS1 NRSN1 NCK2 KLB | 1.68e-05 | 458 | 159 | 14 | int:FGFR4 |
| Interaction | MRAP2 interactions | 3.28e-05 | 77 | 159 | 6 | int:MRAP2 | |
| Interaction | REG4 interactions | 3.91e-05 | 9 | 159 | 3 | int:REG4 | |
| Interaction | AGRN interactions | 5.32e-05 | 267 | 159 | 10 | int:AGRN | |
| Interaction | PITRM1 interactions | 5.75e-05 | 168 | 159 | 8 | int:PITRM1 | |
| Interaction | HRAS interactions | TCF4 LZTR1 HLA-A TTC28 C1orf43 SNX17 JPH2 ITGA2 LSR PTPRF PTPRJ FUBP1 NECTIN1 ARFGAP1 PLCB3 FYN APBB1IP | 6.16e-05 | 725 | 159 | 17 | int:HRAS |
| Interaction | TRIM33 interactions | NID2 TCF4 RANBP2 LHX4 DSP ACLY RNF40 KCTD17 FASN SF3B1 FUBP1 TAF15 ANAPC5 | 6.48e-05 | 453 | 159 | 13 | int:TRIM33 |
| Interaction | SEZ6L interactions | 7.59e-05 | 11 | 159 | 3 | int:SEZ6L | |
| Interaction | KCNC3 interactions | 7.60e-05 | 29 | 159 | 4 | int:KCNC3 | |
| Interaction | LCK interactions | ARHGAP32 UBAP2 DSP RBM3 JPH1 FAM171A1 LSR PTPRC PTPRF PTPRH TOMM34 TNKS1BP1 FYN | 8.08e-05 | 463 | 159 | 13 | int:LCK |
| Interaction | PDGFRB interactions | 8.49e-05 | 228 | 159 | 9 | int:PDGFRB | |
| Interaction | TMEM30A interactions | 8.61e-05 | 132 | 159 | 7 | int:TMEM30A | |
| Interaction | KLK10 interactions | 9.33e-05 | 180 | 159 | 8 | int:KLK10 | |
| Interaction | EP300 interactions | SETD1A TCF4 HLA-A ACLY ASCC1 NUP98 POU3F2 RNF40 AGPS STT3A HOXB1 FASN SF3B1 ZRANB2 RBM14 ACSM5 CCAR2 C3 TAF15 GFPT2 HERC1 BSN ANAPC5 FOXC1 TGS1 | 1.03e-04 | 1401 | 159 | 25 | int:EP300 |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.07e-09 | 21 | 116 | 6 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 8.11e-08 | 160 | 116 | 10 | 555 | |
| GeneFamily | Kelch like|BTB domain containing | 7.02e-06 | 42 | 116 | 5 | 617 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 8.85e-06 | 21 | 116 | 4 | 89 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.10e-05 | 9 | 116 | 3 | 1234 | |
| GeneFamily | RNA binding motif containing | 6.95e-05 | 213 | 116 | 8 | 725 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 2.26e-04 | 134 | 116 | 6 | 861 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.02e-04 | 161 | 116 | 6 | 593 | |
| GeneFamily | Nucleoporins | 1.11e-03 | 32 | 116 | 3 | 1051 | |
| GeneFamily | Lysozymes, c-type | 1.43e-03 | 9 | 116 | 2 | 1174 | |
| GeneFamily | Immunoglobulin like domain containing | 1.54e-03 | 193 | 116 | 6 | 594 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.14e-03 | 40 | 116 | 3 | 321 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 5.84e-03 | 18 | 116 | 2 | 1160 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 6.44e-03 | 115 | 116 | 4 | 769 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | NID2 TCF4 FLT4 HTRA1 DSP PDK4 TTYH2 SIK1 JPH1 LSR ABLIM1 FBLN2 DOK4 ITSN2 PLCB3 PZP TNS1 NOS3 FOXC1 | 1.83e-06 | 888 | 158 | 19 | M39049 |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 5.48e-06 | 210 | 158 | 9 | M1303 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 6.15e-06 | 213 | 158 | 9 | MM1125 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.57e-10 | 199 | 159 | 11 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.65e-10 | 200 | 159 | 11 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.65e-10 | 200 | 159 | 11 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-09 | 186 | 159 | 10 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.49e-09 | 197 | 159 | 10 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.49e-09 | 197 | 159 | 10 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 2.62e-09 | 198 | 159 | 10 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.75e-09 | 199 | 159 | 10 | 180b3997174fd63bdf3b828063a13483eb4cab29 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.75e-09 | 199 | 159 | 10 | 5b140ac88ebc25ce397ae577e48f3e271faf46e7 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.89e-09 | 200 | 159 | 10 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-08 | 173 | 159 | 9 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-08 | 174 | 159 | 9 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-08 | 179 | 159 | 9 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-08 | 179 | 159 | 9 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-08 | 179 | 159 | 9 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-08 | 187 | 159 | 9 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-08 | 187 | 159 | 9 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-08 | 196 | 159 | 9 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-08 | 196 | 159 | 9 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.98e-08 | 197 | 159 | 9 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.98e-08 | 197 | 159 | 9 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.15e-08 | 198 | 159 | 9 | 8d9858dcb21f20d0c040b22a2cae543eaebd54bc | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.15e-08 | 198 | 159 | 9 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.15e-08 | 198 | 159 | 9 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.53e-08 | 200 | 159 | 9 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.53e-08 | 200 | 159 | 9 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-07 | 180 | 159 | 8 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-07 | 180 | 159 | 8 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-07 | 180 | 159 | 8 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-07 | 180 | 159 | 8 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-07 | 184 | 159 | 8 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-07 | 184 | 159 | 8 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-07 | 185 | 159 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.80e-07 | 187 | 159 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.96e-07 | 188 | 159 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.96e-07 | 188 | 159 | 8 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.96e-07 | 188 | 159 | 8 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-07 | 188 | 159 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-07 | 189 | 159 | 8 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-07 | 194 | 159 | 8 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 5.03e-07 | 194 | 159 | 8 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.22e-07 | 195 | 159 | 8 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.22e-07 | 195 | 159 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.64e-07 | 197 | 159 | 8 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.64e-07 | 197 | 159 | 8 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.64e-07 | 197 | 159 | 8 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-F|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.64e-07 | 197 | 159 | 8 | fbff2fb7a8142b88c9dc71aa10980f4350b7e081 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.86e-07 | 198 | 159 | 8 | f006d68e6c51923be7772eea118546a5762e8a5e | |
| ToppCell | medial-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-07 | 198 | 159 | 8 | e4274584512a72270087a1ab104fab449a2f83bc | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.86e-07 | 198 | 159 | 8 | 50852713c017217c79777c95857097103bcf2fbe | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.86e-07 | 198 | 159 | 8 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | medial-Endothelial-Lymphatic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-07 | 198 | 159 | 8 | 41983d405215b974044e2e9e6c212b134336a6fe | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.86e-07 | 198 | 159 | 8 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | medial-Endothelial-Lymphatic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-07 | 198 | 159 | 8 | 1760fede363544bc0fa2e22fe36aff522abd2525 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 6.09e-07 | 199 | 159 | 8 | 3a0af1a13b1760f4213d87d0958dbe3bf3b9a42b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.09e-07 | 199 | 159 | 8 | ccdde5d4bcc72f230a1dd2544ee7f4dfb98a5e80 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.09e-07 | 199 | 159 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.09e-07 | 199 | 159 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.09e-07 | 199 | 159 | 8 | bb2e839197b9a44b632c1bb716e48d885a1c8713 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 6.09e-07 | 199 | 159 | 8 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.33e-07 | 200 | 159 | 8 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-07 | 200 | 159 | 8 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-07 | 200 | 159 | 8 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-07 | 200 | 159 | 8 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.33e-07 | 200 | 159 | 8 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-07 | 200 | 159 | 8 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.33e-07 | 200 | 159 | 8 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-07 | 200 | 159 | 8 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-07 | 200 | 159 | 8 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.29e-06 | 53 | 159 | 5 | 5fa009c9f30c77de6cece40a47da46241f1de54c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.29e-06 | 53 | 159 | 5 | 52a1f2a041e3ba2b11ed753f2f57b78e68b5cc0c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-06 | 153 | 159 | 7 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-06 | 155 | 159 | 7 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 162 | 159 | 7 | 66069146e2666d13c594bd76247893354a697c5d | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 163 | 159 | 7 | 801163c05f8fdacaebd0cb9b4c92741276bfa3e3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-06 | 105 | 159 | 6 | 9ed5482b445eacf16d5769f79438098b0e71123a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.47e-06 | 168 | 159 | 7 | d823979335ac6b5d1f062ebb741c759d2f919dbf | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.47e-06 | 168 | 159 | 7 | f377ff4c066a9857ad14d245e56325ad220e22e1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-06 | 169 | 159 | 7 | a54a8494c1feff29d77ab4737fcfabc84ace5c94 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-06 | 171 | 159 | 7 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-06 | 171 | 159 | 7 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 173 | 159 | 7 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 173 | 159 | 7 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-06 | 175 | 159 | 7 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.62e-06 | 178 | 159 | 7 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-06 | 179 | 159 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-06 | 179 | 159 | 7 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.76e-06 | 179 | 159 | 7 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-06 | 180 | 159 | 7 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.05e-06 | 181 | 159 | 7 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 181 | 159 | 7 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 181 | 159 | 7 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-06 | 182 | 159 | 7 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 118 | 159 | 6 | 811e8521129914eef46785a4227c1860e77d9096 | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 118 | 159 | 6 | 6053e19d040fb394f9c270361af07b0c5a4d47db | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-06 | 183 | 159 | 7 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-06 | 183 | 159 | 7 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 183 | 159 | 7 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-06 | 183 | 159 | 7 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.51e-06 | 184 | 159 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | FLT4 LZTR1 RBM10 GLB1L2 GSK3A KCTD17 KLHL22 LSR FASN PTPRF ARFGAP1 PLCB3 | 1.17e-08 | 193 | 159 | 12 | 3262_UP |
| Drug | AC1L9A0M | 8.62e-07 | 74 | 159 | 7 | CID000440822 | |
| Drug | pyridine borane | 6.58e-06 | 6 | 159 | 3 | CID000123022 | |
| Disease | age related macular degeneration 7 (is_implicated_in) | 2.74e-05 | 2 | 155 | 2 | DOID:0110019 (is_implicated_in) | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 9.16e-05 | 17 | 155 | 3 | DOID:10873 (is_implicated_in) | |
| Disease | factor VIII deficiency (is_marker_for) | 1.63e-04 | 4 | 155 | 2 | DOID:12134 (is_marker_for) | |
| Disease | vulva cancer (is_implicated_in) | 1.63e-04 | 4 | 155 | 2 | DOID:1245 (is_implicated_in) | |
| Disease | Metastatic melanoma | 1.89e-04 | 54 | 155 | 4 | C0278883 | |
| Disease | ras-related protein Rab-26 measurement | 2.71e-04 | 5 | 155 | 2 | EFO_0801989 | |
| Disease | Insulin Resistance | 2.84e-04 | 60 | 155 | 4 | C0021655 | |
| Disease | Insulin Sensitivity | 2.84e-04 | 60 | 155 | 4 | C0920563 | |
| Disease | Congestive heart failure | 2.94e-04 | 110 | 155 | 5 | C0018802 | |
| Disease | Heart failure | 2.94e-04 | 110 | 155 | 5 | C0018801 | |
| Disease | Left-Sided Heart Failure | 2.94e-04 | 110 | 155 | 5 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 2.94e-04 | 110 | 155 | 5 | C0235527 | |
| Disease | Heart Decompensation | 2.94e-04 | 110 | 155 | 5 | C1961112 | |
| Disease | Myocardial Failure | 2.94e-04 | 110 | 155 | 5 | C1959583 | |
| Disease | intraocular pressure measurement | SOX11 TCF4 FOLH1 CHRNE PTPRJ CSPG4 FYN TNS1 ANGPTL7 SLC30A10 | 3.78e-04 | 509 | 155 | 10 | EFO_0004695 |
| Disease | azoospermia (implicated_via_orthology) | 3.79e-04 | 27 | 155 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | ventral hernia | 4.06e-04 | 6 | 155 | 2 | EFO_1001866 | |
| Disease | paroxysmal nocturnal hemoglobinuria (is_implicated_in) | 4.06e-04 | 6 | 155 | 2 | DOID:0060284 (is_implicated_in) | |
| Disease | reticulocyte count | UBAP2 HLA-A ACLY SNX17 PSMB5 PTPRC PTPRH PTPRJ PLCB3 TAF15 HERC1 BSN TNS1 SLC30A10 APBB1IP | 4.21e-04 | 1045 | 155 | 15 | EFO_0007986 |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 4.23e-04 | 28 | 155 | 3 | DOID:12236 (biomarker_via_orthology) | |
| Disease | retinal degeneration (biomarker_via_orthology) | 4.23e-04 | 28 | 155 | 3 | DOID:8466 (biomarker_via_orthology) | |
| Disease | cognitive function measurement | TCF4 TTC28 DSP POU3F2 CSMD3 MSI2 IL1RAPL1 LSR PTPRD PTPRF ITSN2 CNTNAP4 BACE2 FYN MUC2 TNR SLC30A10 MAML3 | 5.55e-04 | 1434 | 155 | 18 | EFO_0008354 |
| Disease | Pulmonary Edema | 5.66e-04 | 7 | 155 | 2 | C0034063 | |
| Disease | Squamous cell carcinoma of lung | 6.31e-04 | 32 | 155 | 3 | C0149782 | |
| Disease | corneal resistance factor | 6.63e-04 | 451 | 155 | 9 | EFO_0010067 | |
| Disease | sensory perception of taste | 6.91e-04 | 33 | 155 | 3 | GO_0050909 | |
| Disease | Liver Cirrhosis, Experimental | NID2 TCF4 RBM3 ACP5 SRI ADIPOQ PTPRC PTPRD FYN NOS3 PLTP APBB1IP | 8.31e-04 | 774 | 155 | 12 | C0023893 |
| Disease | pneumonia (implicated_via_orthology) | 1.20e-03 | 10 | 155 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | nasopharyngeal neoplasm | 1.24e-03 | 151 | 155 | 5 | EFO_0004252 | |
| Disease | colitis (biomarker_via_orthology) | 1.40e-03 | 42 | 155 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | Paranoia | 1.46e-03 | 11 | 155 | 2 | C1456784 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.75e-03 | 12 | 155 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | TDRD15 TCF4 FOLH1 IFT172 SNX17 POU3F2 NLGN1 PTPRF TNKS1BP1 BSN LYZ ANAPC5 MAML3 PLTP ARHGAP33 | 1.78e-03 | 1206 | 155 | 15 | EFO_0004458 |
| Disease | end stage renal disease (biomarker_via_orthology) | 1.95e-03 | 47 | 155 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.19e-03 | 49 | 155 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | diabetic retinopathy (is_implicated_in) | 2.33e-03 | 50 | 155 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | treatment-resistant hypertension | 2.66e-03 | 109 | 155 | 4 | EFO_1002006 | |
| Disease | atherosclerosis (is_implicated_in) | 3.13e-03 | 16 | 155 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | Tetralogy of Fallot | 3.13e-03 | 16 | 155 | 2 | C0039685 | |
| Disease | sickle cell anemia (is_implicated_in) | 3.13e-03 | 16 | 155 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | amino acid measurement | 3.21e-03 | 678 | 155 | 10 | EFO_0005134 | |
| Disease | Astrocytosis | 3.54e-03 | 17 | 155 | 2 | C3887640 | |
| Disease | Antibody Deficiency Syndrome | 3.54e-03 | 17 | 155 | 2 | C0003257 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.54e-03 | 17 | 155 | 2 | EFO_0022232 | |
| Disease | Gliosis | 3.54e-03 | 17 | 155 | 2 | C0017639 | |
| Disease | essential hypertension (is_implicated_in) | 3.97e-03 | 18 | 155 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | adenosine monophosphate measurement | 3.97e-03 | 18 | 155 | 2 | EFO_0010454 | |
| Disease | triacylglycerol 56:3 measurement | 3.97e-03 | 18 | 155 | 2 | EFO_0010430 | |
| Disease | Age-related macular degeneration | 3.97e-03 | 18 | 155 | 2 | cv:C0242383 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.97e-03 | 18 | 155 | 2 | HP_0002373 | |
| Disease | age at menarche | 4.29e-03 | 594 | 155 | 9 | EFO_0004703 | |
| Disease | Hydrops Fetalis | 4.42e-03 | 19 | 155 | 2 | C0020305 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 4.42e-03 | 19 | 155 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | cardiomyopathy (is_implicated_in) | 4.42e-03 | 19 | 155 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 4.42e-03 | 19 | 155 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 4.42e-03 | 19 | 155 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | NID2 RBM3 UBR4 SMC6 NUP98 TECTA FASN PTPRC PTPRD ITSN2 ANAPC5 TNS1 NOS3 | 4.49e-03 | 1074 | 155 | 13 | C0006142 |
| Disease | Malignant Neoplasms | 4.72e-03 | 128 | 155 | 4 | C0006826 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.74e-03 | 206 | 155 | 5 | C0152013 | |
| Disease | Fetal Growth Retardation | 4.90e-03 | 20 | 155 | 2 | C0015934 | |
| Disease | mean arterial pressure | 5.01e-03 | 499 | 155 | 8 | EFO_0006340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGAQRLGSIAAYGFN | 591 | Q96P26 | |
| YRSLQYSRQEGLDGG | 756 | Q8N163 | |
| GRNYIVDAGFGRSYQ | 116 | P18440 | |
| VDNLQGDSGRGYYLE | 81 | Q9Y5Z0 | |
| AEALEQLNSGYYVSG | 301 | O75150 | |
| YDGGDNNAPRLGSYS | 1996 | Q7Z407 | |
| GFTQDDIQAGRVTYG | 846 | Q6UVK1 | |
| DFAQYNSYGDVSGGV | 671 | O14639 | |
| NSYGDVSGGVRDYQT | 676 | O14639 | |
| YGEGERNGLYADNDN | 216 | Q15848 | |
| GYGTNVAATGISQYE | 111 | Q7Z5R6 | |
| GFSGNANADSVVYYR | 131 | Q9C0A0 | |
| LNEQRYYGGGYGSTQ | 1256 | P01024 | |
| GTGSANSYGLYTIRD | 396 | Q86Y34 | |
| QTGVELYEGYGQSET | 361 | Q6NUN0 | |
| DLGSYQGAQGNRYVG | 171 | Q8N6T3 | |
| DPNAEGRYNLYTAEG | 316 | Q8N9N2 | |
| GVAYDANVLVYEGGS | 121 | Q04844 | |
| GSGLNSFYDQREYIG | 586 | P49792 | |
| DVSRYGEDNRGYGGS | 166 | Q92804 | |
| DEGYGNSQGTESSLY | 441 | P98175 | |
| AAASYRGQPGNAYDG | 536 | Q96PK6 | |
| YSTFGERYGRNQGNT | 1031 | P20742 | |
| GYGYGRSRDYNGRNQ | 126 | P98179 | |
| YGPASQDSGVGNYIS | 286 | Q96DH6 | |
| SNGVRVTGYAIYADG | 1011 | O95153 | |
| DDGFYYGELNGQRGL | 1806 | O95153 | |
| SGGYITGDQARNFFL | 36 | Q9NZM3 | |
| DYSAILYLNGDFDGG | 611 | Q32P28 | |
| DGDYINANYIRGYDG | 146 | P35236 | |
| GDLNLYSLSGYGTDA | 346 | Q16654 | |
| QPGNYSCSYRTDGEG | 176 | P04217 | |
| SYRLFLGNYTGNVGN | 246 | O43827 | |
| NGEEGYGRSLRYAAL | 291 | Q9UJX4 | |
| GYGSIYFEGDVNLTN | 771 | P52948 | |
| IDVGNESTTLGYYNG | 906 | Q12913 | |
| GNDDYRGSYNTVLSQ | 481 | Q5VUB5 | |
| RDNGGDAASNLLYRY | 356 | Q8N4N3 | |
| NNGLQDGYGTETYAD | 111 | Q9BR39 | |
| ETYADGGTYQGQFTN | 121 | Q9BR39 | |
| AIYENTREGYTGFGL | 61 | Q96KX0 | |
| YIFGGTVDNNIRSGE | 401 | Q8N653 | |
| TNYNAGDRSTDYGIF | 61 | P61626 | |
| GGQVRDEYRQDYDAG | 131 | P52298 | |
| DYDAGRGGYGKLAQN | 141 | P52298 | |
| DAEYPANGSGADRIY | 96 | O43639 | |
| RNAPQDVSYNYSGDG | 1086 | Q96JK9 | |
| SVFREGNAYTLAGGQ | 86 | A6NFK2 | |
| GGSIIYLNDSVYDGA | 206 | Q16832 | |
| TSLNSNDYGYGGQKR | 51 | Q96AE4 | |
| RGSYSSYGRESNLQG | 106 | P15884 | |
| GVAYINADSSIEGNY | 446 | Q04609 | |
| ANRQGYRSNGSYVDG | 3006 | Q15751 | |
| SNGLQDGYGVETYGD | 111 | Q9HDC5 | |
| RYLGQGLQYGSVTDL | 2031 | Q9UPA5 | |
| ADDGASFGSVYIYNG | 606 | P38570 | |
| EEGYFGTRRLNAYTG | 1126 | P98095 | |
| YDGGYINASAEGVSI | 111 | P55058 | |
| EGDLGNYSCYVENGN | 326 | Q9NZN1 | |
| DYNGLQSYSEFLSDG | 171 | Q02817 | |
| QFALEAGGYQAGAAR | 346 | P41219 | |
| AYNFLVGDDGRVYEG | 116 | Q96LB8 | |
| RQAQAAAEGGYQRYG | 11 | Q8IZ57 | |
| RSNYDQYGDAGENQG | 86 | Q9Y2G8 | |
| GNFLYVVGGQSNYDT | 346 | Q9P2J3 | |
| GGRALYEGYATVTDA | 636 | Q9NY33 | |
| GQSYQDLRDGSPYGI | 296 | Q969G2 | |
| TRQNVEGSYDGAYAP | 1251 | P00451 | |
| EGTGNLYDGSVLASY | 226 | Q8N2Q7 | |
| DSGNLIAYGGNNYVV | 31 | Q8NFH4 | |
| RPGTSQAGYTNYGDI | 1061 | A7KAX9 | |
| GGDLTNTFGAIQYAR | 246 | P17301 | |
| QYFGRSLDGYGDLNG | 616 | P17301 | |
| VNIGSSYNYGSEDQA | 171 | Q8N5Z5 | |
| SREYGGEGTDFYQVR | 671 | Q9UG01 | |
| YAGYRQQDGSVRGDP | 251 | P29474 | |
| EGSDYINASFIDGYR | 1731 | Q13332 | |
| AYIVGNDGRAYTAIS | 556 | Q14112 | |
| NAGVFEYNGRSGYLL | 686 | Q01970 | |
| RGENLYYEIGASEGS | 1081 | O14559 | |
| IYYGDNRFNTVSESG | 51 | Q5T0Z8 | |
| LGGNLTENYYDSFDT | 2001 | Q9C0G6 | |
| AQAVDSYASEGRYGG | 36 | P14653 | |
| YIQTDAIINYGNSGG | 316 | Q92743 | |
| GNGSFGVVYQARLAE | 126 | P49840 | |
| LDGNLYAVGGYDSSS | 481 | Q6TDP4 | |
| LDGQIYVCGGYDGNS | 381 | O94889 | |
| LYAVGGYDGQSNLSS | 526 | O94889 | |
| YVIGGSNNDAGYRRD | 496 | Q53GT1 | |
| YETARYGTGVFGQNE | 161 | Q9BWL3 | |
| EYRGYDSAGVAIDGN | 31 | O94808 | |
| QLYAENSRGGYDSGP | 131 | A2CJ06 | |
| GEQSYYRAAAAAAGG | 21 | Q12948 | |
| RNDYGTSGFSEEVLY | 446 | Q9Y2H6 | |
| EERDGSLNQSSGYRY | 16 | P06241 | |
| EEQRYGGGFYSTQDT | 1276 | P01031 | |
| YYSRRGVITDQNSDG | 41 | P15924 | |
| DLGTLRGYYNQSEAG | 101 | P04439 | |
| YSGGAGYVRSSQDLS | 161 | Q8N1E2 | |
| NNEGSLLAYSGYGDT | 26 | Q9Y2Q5 | |
| RISDRTNYGEEGSAY | 736 | Q8N7U6 | |
| RLSDIYNRSGNDTYG | 696 | Q86Z14 | |
| SVGQYDNRGSFGELA | 196 | P13861 | |
| TLSGQGRLYDYGQRF | 681 | Q8IZU9 | |
| NGGNGQSFGYILYET | 421 | Q8IW92 | |
| GNYIGQVLVTADDYG | 526 | Q05BV3 | |
| SGYVNQLSAGYESVD | 326 | Q15007 | |
| YVAGRFGQDDSTGYV | 711 | P82279 | |
| GGAYGEDLGADYNLS | 2451 | P49327 | |
| SLNVGEDYGVSAYRT | 536 | Q16348 | |
| AEASSYAGEGYGAAQ | 281 | Q8TEW6 | |
| YAGEGYGAAQASSET | 286 | Q8TEW6 | |
| QGYNATLLAYGQTGS | 101 | B7ZC32 | |
| GNAVTLGDYYQGRRI | 181 | Q86X29 | |
| GSDYINASFLDGYRQ | 1691 | P10586 | |
| GSDYINASFIDGYRQ | 1696 | P23468 | |
| GSTTGFLQYAYDGQD | 126 | Q95460 | |
| IFSASNYYEEGSNRG | 421 | O14829 | |
| GSVQGDYYGDLAARL | 86 | Q16674 | |
| SIYDSGDRQGLLGAY | 401 | Q9GZY0 | |
| GTYGIVYAGRDLSNQ | 661 | Q6ZN16 | |
| AQSGDYGGAGDDYVL | 186 | P35716 | |
| YINGDAAVSEGYAAD | 101 | Q9BWW7 | |
| SDGQLGIELYDGSQY | 1116 | B5MCY1 | |
| GRGLNSSYDQQEYIG | 586 | P0DJD1 | |
| FYYNRDSENSQSLGG | 226 | P00797 | |
| NGYTREAYFSVGLQG | 381 | Q5JRX3 | |
| GYISRSVAGSYDNEG | 156 | P46977 | |
| DALQGQGVYTYEDGG | 66 | Q8WTS6 | |
| SYTSNLGDYDEQALG | 296 | A0A0B4J2F2 | |
| SYTSNLGDYDEQALG | 296 | P57059 | |
| AANNYARGRYSVGSE | 106 | A6NHL2 | |
| AGGYREAQSLVQGDY | 31 | P20265 | |
| LRITYGQGSGTAVYN | 321 | Q6UX06 | |
| ALYAQGQEGRGAYSR | 731 | O15047 | |
| QSERLYGSYVFGDRN | 501 | Q96QV1 | |
| GGVNELANYGEYSGA | 296 | P53396 | |
| AGEDNGQRGYLLTYV | 496 | O00116 | |
| STYGLCGRYNGNPDD | 1236 | O75443 | |
| RSGDSGGSAYVAYNI | 11 | Q15036 | |
| TYGYARAEVVGALSN | 71 | Q6XR72 | |
| RNGQYAEASALYGRA | 21 | Q15785 | |
| GYDDLTQGTAAGDYS | 966 | Q5T6F2 | |
| YEEYQGRSLDANSGG | 471 | Q8N7X1 | |
| YEEYRGRSLDANSGG | 591 | Q8N7X1 | |
| SSQSNRYGGGGRYEE | 696 | Q8N7X1 | |
| DEAQGVGLDSTGYYD | 26 | O75533 | |
| QEIYGGSDSRFAGYV | 41 | O75533 | |
| VGFYGNSETNDGAYQ | 106 | Q9BSA4 | |
| SYQFGIIGNDRVSGA | 1121 | Q9C0C2 | |
| ARGGQVFYNSEYGEL | 1326 | P35916 | |
| SYSAQEGLAGYQREG | 581 | Q9HBL0 | |
| RIGSYNGTAGDSLSY | 1256 | Q92752 | |
| YLQDENGVGYVLSGA | 246 | P13686 | |
| GDQVFAGRYYSSENT | 641 | Q96SB8 | |
| EVSYAGDNFVRYTGD | 306 | O95391 | |
| VAANNLGFGEYSGIS | 1831 | P08922 | |
| GYGGGFNERENVEYI | 101 | O95218 | |
| GNAIQARSSSYSGEY | 16 | O60844 | |
| QGRAYGNLGLTYESL | 1036 | Q96AY4 | |
| YYIRDSGNNSGDQAT | 46 | Q96RS0 | |
| QATYRDAYSGGAVNL | 221 | P28074 | |
| DSNSQVAGGGVSVYY | 2101 | Q5T4S7 | |
| GDAGSNYINASYIDG | 701 | P08575 | |
| DPQNSTYGVEYTGDG | 146 | Q9HD43 | |
| QNSTYGVEYTGDGGR | 326 | Q9HD43 | |
| YGYFAAVAGQDGQID | 36 | P30626 | |
| FGALYYGGESQNDLR | 311 | Q6ZMR5 | |
| GYLNEDGELGLAYQG | 1321 | Q9ULV0 | |
| SNYRDVQYFGEIGLG | 71 | O96009 | |
| ARQDGYGDRTLGYQY | 476 | Q15223 |